PITTSBURGH — A breakthrough treatment to help women suffering from an aggressive form of breast cancer was released Saturday.
The University of Pittsburgh and UPMC Hillman Cancer Center published results from a new trial.
It was the first large clinical trial to support the use of immunotherapy in breast cancer patients and the results were very encouraging.
TRENDING NOW:
Triple negative breast cancer is very aggressive and affects about 20 percent of all breast cancer patients.